Protein Information

ID 825
Name PF6
Synonyms PF6; Projection protein PF6; RP4 776P7.2; SPAG17; sperm associated antigen 17; Projection protein PF6s; sperm associated antigen 17s

Compound Information

ID 1404
Name phosphine
CAS phosphine

Reference

PubMed Abstract RScore(About this table)
15792474 Benny PD, Green JL, Engelbrecht HP, Barnes CL, Jurisson SS: Reactivity of rhenium (V) oxo Schiff base complexes with phosphine ligands: rearrangement and reduction reactions. Inorg Chem. 2005 Apr 4;44(7):2381-90.
The symmetric rhenium (V) oxo Schiff base complexes trans-[ReO (OH2)(acac2en)] Cl and trans-[ReOCl (acac2pn)], where acac2en and acac2pn are the tetradentate Schiff base ligands N,N'-ethylenebis (acetylacetone) diimine and N,N'-propylenebis (acetylacetone) diimine, respectively, were reacted with monodentate phosphine ligands to yield one of two unique cationic phosphine complexes depending on the ligand backbone length (en vs pn) and the identity of the phosphine ligand. Reduction of the Re (V) oxo core to Re (III) resulted on reaction of trans-[ReO (OH2)(acac2en)] Cl with triphenylphosphine or diethylphenylphosphine to yield a single reduced, disubstituted product of the general type trans-[Re (III)(PR3) 2 (acac2en)]+. Rather unexpectedly, a similar reaction with the stronger reducing agent triethylphosphine yielded the intramolecularly rearranged, asymmetric cis-[Re (V) O (PEt3)(acac2en)]+ complex. Reactions of trans-[Re (V) O (acac2pn) Cl] with the same phosphine ligands yielded only the rearranged asymmetric cis-[Re (V) O (PR3)(acac2pn)]+ complexes in quantitative yield. The compounds were characterized using standard spectroscopic methods, elemental analyses, cyclic voltammetry, and single-crystal X-ray diffraction. The crystallographic data for the structures reported are as follows: trans-[Re (III)(PPh3) 2 (acac2en)] PF6 (H48C48N2O2P2Re.PF6), 1, triclinic (P), a = 18.8261 (12) A, b = 16.2517 (10) A, c = 15.4556 (10) A, alpha = 95.522 (1) degrees , beta = 97.130 (1) degrees , gamma = 91.350 (1) degrees , V = 4667.4 (5) A (3), Z = 4; trans-[Re (III)(PEt2Ph) 2 (acac2en)] PF6 (H48C32N2O2P2Re.PF6), 2, orthorhombic (Pccn), a = 10.4753 (6) A, b =18.4315 (10) A, c = 18.9245 (11) A, V = 3653.9 (4) A3, Z = 4; cis-[Re (V) O (PEt3)(acac2en)] PF6 (H33C18N2O3PRe.1.25PF6, 3, monoclinic (C2/c), a = 39.8194 (15) A, b = 13.6187 (5) A, c = 20.1777 (8) A, beta = 107.7730 (10) degrees , V = 10419.9 (7) A3, Z = 16; cis-[Re (V) O (PPh3)(acac2pn)] PF6 (H35C31N2O3PRe.PF6), 4, triclinic (P), a = 10.3094 (10) A, b =12.1196 (12) A, c = 14.8146 (15) A, alpha = 105.939 (2) degrees , beta = 105.383 (2) degrees , gamma = 93.525 (2) degrees , V = 1698.0 (3) A3, Z = 2; cis-[Re (V) O (PEt2Ph)(acac2pn)] PF6 (H35C23N2O3PRe.PF6), 5, monoclinic (P2 (1)/n), a = 18.1183 (18) A, b = 11.580 (1) A, c = 28.519 (3) A, beta = 101.861 (2) degrees , V = 5855.9 (10) A (3), Z = 4.
1(0,0,0,1)